Bharat Biotech Gets WHO Nod For ‘Game-Changer’ Typhoid Vaccine
India’s Bharat Biotech has won WHO pre-qualification for a vaccine against typhoid fever that experts say will be a “game-changer” in preventing the bacterial disease, especially among children under two years - the age group most at risk.
You may also be interested in...
Bharat hopes to expand international reach of Chiron Behring’s rabies vaccine. WuXi and Biolingus partner on sublingual delivery.
Trial-related challenges in India appear to have pushed vaccine maker Bharat Biotech towards opting for alternative sites for studies on its tetravalent vaccine. The firm says it has justified its position to the regulator, though some experts advise diligence in site selection.
The US Supreme Court has lifted a stay on document discovery in a multi-state lawsuit in which dozens of generics companies – including Teva, Mylan and Pfizer – are accused of price fixing. The ruling will allow a swathe of documents to be released in what Connecticut’s attorney general has said is potentially “the largest cartel case” in US history.